Harel Insurance Investments & Financial Services Ltd. Vbi Vaccines Inc Transaction History

Harel Insurance Investments & Financial Services Ltd.

  • $5.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 23, 2020
SELL
$0.48 - $1.38 $733,480 - $2.11 Million
-1,528,085 Closed
0 $0
Q2 2019

Jul 22, 2019
SELL
$0.65 - $2.12 $71,890 - $234,472
-110,600 Reduced 6.75%
1,528,085 $1.79 Million
Q1 2019

Apr 18, 2019
SELL
$1.54 - $2.01 $1,014 - $1,324
-659 Reduced 0.04%
1,638,685 $3.06 Million
Q4 2017

Feb 01, 2018
BUY
$3.29 - $5.03 $5.39 Million - $8.25 Million
1,639,344
1,639,344 $7 Million

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About VBI Vaccines Inc

VBIV Quotes by TradingView
  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email